Company: SXTPW
Filing Date: 2025-03-27
Form Type: S-1/A
Source: 0001013762-25-003353
Chunk: 258

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: S-1/A
Chunk 258
---
95per share. The February 2025 Warrants are exercisable upon issuance, or February 6, 2025, and expire twenty-four months from the date of issuance, or February 8, 2027. As compensation for acting as the placement agent for the February 2025 Offering, the Company paid H.C. Wainwright & Co., LLC a cash transaction fee equal to 7.5% of the aggregate gross cash proceeds in the offering and a management fee equal to 1.0% of the aggregate gross cash proceeds in the offering. The Company also issued to H.C. Wainwright & Co., LLC warrants (the “February 2025 Placement Agent Warrants”) to purchase up to 22,554shares of common stock. The February 2025 Placement Agent Warrants have an exercise price equal to $ 4.469per share and are exercisable upon issuance, or February 6, 2025, and expire twenty-four months from the date of issuance, or February 8, 2027. The February 2025 Offering closed on February 6, 2025, resulting in net proceeds to the Company of approximately $ 908,627, after deducting the placement agent fees and other offering expenses paid by the Company. 1:5 Reverse Stock Split On February 18, 2025, the Company filed an amendment to its Certificate of Incorporation with the Secretary of State of Delaware to effect the 1:5 Reverse Stock Split, which was effective as of February 24, 2025. The Company’s stockholders approved a reverse stock split at a ratio ranging from 1:3 to 1:5 at the 2024 Special Stockholders Meeting on November 6, 2024, and subsequently on February 10, 2025, the Company’s Board of Directors approved the implementation of the reverse stock split at a ratio of 1:5. As of the effective time of the 1:5 Reverse Stock Split, every five (5) issued and outstanding shares of the Company’s common stock were automatically combined and converted into one (1) issued and outstanding share of the Company’s common stock, reducing the number of shares of common stock outstanding from 7,364,554shares to 1,472,891shares. The 1:5 Reverse Stock Split did not change the authorized number of shares of common stock or preferred stock. Proportional adjustments were made to the number of shares of common stock issuable